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Abstract. To decrease immunogenicity of the rat kidney, 
grafts were perfused with an anti-MHC class li monoclo-
nal antibody (mAb ). How effectively this procedure 
blocked dass li-positive cells, which were mainly den-
dritic in appearance, was checked by immunostaining 
renal sections after perfusion and comparing them with in 
vitro stained sections. Optimum conditions were applied 
for graft pretreatment before transplantation. This proce-
dure prolonged graft survival, though not satisfactorily 
from the biological point ofview (9.6 ± 0.8 versus 7.7 ± 0.5 
days in the control group; P < 0.02). The dendritic cells 
were not killed but blocked. Several hours after transplan-
tation, the mAb dissociated from these dass li-positive 
cells. It was also shown that donor cells migrate into the re-
cipient's spieen early after transplantation. The number of 
these cells was smaller when the transplanted organ was 
perfused with the mAb. Further studies are suggested to 
deplete the graft of donor dendritic cells more adequately. 
They should also combine graft perfusion with anti-
dass II mAb and recipient immunosuppression at re-
duced doses. 
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The immunogenicity of the graft and the immunological 
reactivity of the recipient are the main factors that deter-
mine allogeneic graft rejection. Immunogenicity depends 
on the presence of minor and major histocompatibility 
complex (MHC) class I and II gene products on the cell 
surface. It has been shown that class II antigen expression 
is not stable, and various protocols may change the extent 
to which these antigens are expressed [1, 2, 16, 19, 22, 24, 
25). It has also been demonstrated in studies on the heart 
and pancreas [3, 21] that rat strains may be divided into 
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two groups. One has a high density of interstitial dendritic 
cells (DC) that express class II antigens and the other a 
low density. For successful transplantationindifferent rat 
strain combinations, it may be advantageaus to know the 
dass II MHC antigen expression and to take it into ac-
count. 
To decrease the immunogenicity of the graft, various 
procedures have been used [4, 9, 13, 14, 17, 18, 23]. Evi-
dence is accumulating to support the hypothesis that graft 
immunogenicity may be altered by pretreatment with 
anti-class II monoclonal antibodies. However, evidence 
of the effectiveness of perfusion procedures, as presented 
in the literature, is quite fragmentary. 
In the present study, MHC dass II antigen expression 
was investigated in rat renal grafts to analyze the effective-
ness of the perfusion procedure in pretreating the graft 
and to define the optimum conditions for blocking dass II 
antigens expressed on DC. The efficacy of the method was 
assessed morphologically by the immunoperoxidase tech-
nique on renal tissue sections. Kidneys pretreated under 
optimum conditions were used for allogeneic rat trans-
plantation. 
Materials and methods 
Animals 
InbredmaleLEW(RT1l),DA(RT1 a), andCAP (RTl c)rats,bred 
in our department, were used in the study. Allrats were 3-4 months 
old. Male DA and LEW rats were used as transplant donors and 
recipients. 
Monoclonal antibodies (mAb) 
Organperfusions were done with an anti-dass II mAb (29A1) of the 
IgGl typethat reacts with the I-E subregion. This mAb was pro-
duced at the Department oflmmunology in KieL For irnmunoperox-
idase staining, the following mAbs were also used: MRC Ox6, which 
reacts with monomorphic determinant of rat dass II antigen (1-A re-
gion), and MRC Ox3, directed against a polymorphic determinant of 
dass ll antigen present on cells from animals of the LEWstrain but 
not of the DA or CAP strains (Serotec, K.idlington, Oxford, UK). 
Organperfusion 
The left kidney was removed under ether anestbesia, perfused with 
1.5 m1 of cold pbosphate-buffered saline (PBS) and then with mAb 
29Al (2.0 ml culture supernatant + 0.5 ml20% glucose ), and placed 
into an ice-cold bath for 20, 30, 60, or 120 min. Thekidney fragments 
were snap-frozen and stored at - so·c. 
Histology 
Seven-micrometer cryostat sections were cut, air-dried, fixed in 
acetone, and stored at - 2o·c until use. MHC dass II antigen ex-
pression in argans perfused with cold PBS was demonstrated using a 
three-stage immunoperoxidase technique. The first step was to incu-
bate the organ sections witb the mAb. In two further steps, peroxi-
dase - conjugated antiglobulin antiborlies were used: rabbit anti-
mause Ig (Dianova, Hamburg, FRG) and goat anti-rabbit Ig (Daco, 
Copenhagen, Denmark). After staining with diaminobenzidine, the 
slides were colared with hematoxylin. Sections of organs perfused 
with 29A1 were analyzed for the effectiveness of mAb binding to 
dass rr antigen-positive cells with the two-stage immunoperoxidase 
technique, the second and the third stages of the three-stage method. 
Renaltransplantation 
Renal transplantations were performed according to the method 
employed by Lee [12] on rats weighing 250- 300 g. In brief, the donor 
kidney was perfused with mAb 29Al and incubated at 4 ·c for 
60 min. Both of the recipient's own kidneys were removed. After in-
cubation, the mAb was washed out of the donor kidney with PBS. 
The distal aorta and vena cava of the graft were connected to the re-
Table 1. Survey of MHC dass li antigen expression on cells of the 
normal rat kidney in various inbred strains and an analysis of its 
ontogenesis 
Rat Age Oass li-positive cells Staining intensity 
strain (weeks) Cells/glomerulus Interstitial of dendritic cells
8 
cells/mm2 
n x±SD n x±SD 
DA 3 18 0.1 ±0.3 11 103±30 2+ 
(RTl a) 6 21 0.8±0.7 11 96±25 4+ 
9 21 1.6± 1.4 11 113 ± 19 4+ 
12 36 0.9± 1.0 39 78±24 4+ 
3- 6 P<0.05 NS 
3- 9 p <0.05 NS 
3-12 p <0.05 NS 
LEW 3 19 0 23 19±11 1+ 
(RTll) 6 35 0.6±0.7 19 23±11 2+ 
9 24 1.5 ± 1.2 19 37±16 3+ 
12 64 1.2 ± 1.4 38 38±21 4+ 
3- 6 NS NS 
3-9 NS p <0.01 
3-12 NS p <0.01 
CAP 3 29 0.1 ±0.3 15 78±30 3+ 
(RTl c) 6 24 2.2± 1.5 14 80±16 4+ 
9 20 3.4 ± 1.6 11 127±26 4+ 
12 70 2.1± 1.5 27 78±23 4+ 
3- 6 p <0.01 NS 
3-9 p <0.01 p <0.05 
3-12 p <0.01 NS 
DA 12-LEW 12 NS P<O.Ol 
CAP 12 - LEW 12 p <0.05 p <0.01 
a Grading of staining intensity: 1 + , weak; 2 + , medium; 3 + , strong; 
4 + , very strong 
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Flg.l. Constitutive expression of MHC class II antigen in normal rat 
kidney. Sections of LEW rat kidney incubated with an anti-dass II 
mAb (Ox6) and identified by the immunoperoxidase method. Inter-
stitial dendritic cells and the cytoplasm of epithelial cells in proximal 
tubules are stained 
spective structures of the recipient via end-to-side anastomoses. A 
ureter-ureter anastomosis was constructed over a fine polyethylene 
internal stent. The warm ischernia time did not exceed 20 min. If an 
obvious technical failure accounted for the death oftherecipient, the 
animal was excluded from the study. Kidneys were transplanted in 
the following groups: (a) LEW to LEW for technical control after 
kidney perfusion; (b) group 1: DA to LEW, kidneys perfused with 
PBS; (c) group 2: DA to LEW, kidneys perfused with mAB 29A1; 
(d) group 3: LEW to DA, kidneys perfused with mAb 29Al; and 
(e) group 4: DA to LEW, kidneys perfused with mAb 29Al, anti-
mouse IgG, and complement or mAb 29A1 and complement. Graft 
rejection was defined as death of the animal. 
Results 
Constitutive expressionof MHC class I/antigens 
in the rat kidney 
Our first study dealt with the constitutive expression of 
dass II antigens on rat kidney cells because we wanted to 
know how many of these cells bind the mAb when the 
graft has been perfused with an anti-dass II mAb. Table 1 
presents the results of the in vitro immunohistological 
analysis of the labelling of dass II -positive cells with mAb 
29Al. The localization of these cells was predominantly 
interstitial, especially between renal tubules. The glome-
ruli contained some densely stained cells, localized within 
the mesangium. The mean number of dass li-positive 
cells per square millimeter varied significantly between 
rat strains (P < 0.01). Figure 1 shows the constitutive ex-
pression of dass II antigen in the normal rat kidney. 
Ontogenesis of class II expression in the rat kidney 
Table 1 also presents results of the analysis of class II 
antigen expression by cells ofthe rat kidney in various age 
groups in three studied strains. In all of these strains, 
3-week-old rats had a significantly lower number of posi-
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Fig.2. Labelling of class li-positive cells in LEW rat kidney after 
perfusion with mAb 29Al and 60 min of incubation. Sections of kid-
ney incubated with anti-immunoglobulin conjugated with peroxi-
dase. Staining of interstitial dendritic cells between tubules 
tive cells per glomerulus than 6- and 12-week-old rats 
(P < 0.05-0.01). The nurober of class !I-positive intersti-
tial cells in 3-week-old DA and CAP ratswas similar to 
that in 12-week-old rats. In kidneys from the LEW strain, 
however, the nurober of dass li-positive interstitial cells 
was significantly smaller than in 9- and 12-week-old rats 
(P < 0.01), and the staining intensity was weaker. 
Labelling of class li-positive cells 
by monoclonal antibody 
Table 2 presents the results of the binding of class li-posi-
tive cells by ex vivo perfusion with mAb 29Al, followed 
by incubation for varying periods of time. These studies 
showed that perfusion with themAband a 60-min incuba-
tion procedure are sufficient to label all cells that express 
dass II antigen. Therefore, this procedure was accepted 
for pretreatment of grafts prior to transplantation. An 
example of dass II antigen-positive cells labelled by the 
mAb is presented in Fig. 2. 
Rat kidney transplantation 
Table 3 presents the results of kidney transplantation with 
and without graft pretreatment with mAb 29Al. Block-
ade of dass li-positive cells with themAbin a perfusion 
procedure was able to prolong graft survival significantly. 
To investigate how mAb pretreatment of grafts with 
varying densities of interstitial DC affects graft survival, 
transplantation was done in two different systems. In the 
first- DA-to-LEW- the graft had a high density of DC, 
andin the second- LEW-to-DA- the density was low. 
Yet, no difference in graft survival was found between 
these groups. IgG1 mouse antibody is known not to acti-
vate complement. Therefore, to induce cytolysis of DC 
within grafts, perfusion was followed by a second perfu-
sion with anti-mause immunoglobulin and complement or 
complement alone. These procedures did not, however, 
prolong graft survival either. 
Analysis of dissociation of the mAb from cells 
after transplantation 
To answer the question how long the mAb is bound to 
dass li-positive cells after transplantation, three kidneys 
in each group were explanted after 4, 8, 24, and 48 h. Sec-
tians of all kidneys were stained with Ox3, Ox6, or anti-
immunoglobulin conjugated with peroxidase only (to de-
tect mAb 29Al on the cell surface ). Four hours after 
transplantation, 37.5 ± 2.4 DC/mm2 were labelled and 
Table 2. LabeHingof cells expressing dass H MHC antigen by vari-
ous perfusion-incubation procedures with the anti-class II monoclo-
nal antibody 29Al 
Rat No.of Incubation Cells marked with mAb 29Al Staining 
strain argans time Cells/glo- Interstitial intensity
8 
(min) 
merulus DOmm2 
n x±SD n X ±SD 
DA 2 30 41 1.8 ± 1.8 24 73±19 2+ 
2 60 21 1.7 ± 1.5 17 100±32 3 + 
2 120 40 1.5 ± 1.0 21 95 ± 23 3+ 
30-Normal expressionb NS NS 
60-Normal expressionb NS NS 
120-Normal expressionb NS NS 
LEW 2 30 36 0.8±0.8 11 50±18 2 + 
1 60 40 0.6±0.5 22 50±17 2 + 
2 120 35 1.5 ±2.1 50 53±17 3+ 
30-Normal expressionb NS NS 
60-Normal expressionb NS NS 
120-Normal expressionb NS p <0.05 
CAP 1 20 38 1.1 ± 0.9 15 8± 10 1+ 
2 30 30 2.6±1.4 20 89± 18 2+ 
2 60 43 2.0 ± 1.2 25 91±28 3+ 
2 120 47 1.6 ± 1.2 20 86±24 3 + 
2~30 p <0.02 p <0.001 
20-Normal expressionb p <0.02 p <0.001 
30-Normal expressionb NS NS 
60-Normal expressionb NS NS 
120-Normal expressionb NS NS 
• Grading of staining intensity : 1 + , weak; 2 +,medium; 3 +, streng; 
4 + , very streng 
b Normal expression: nurober of dass li-positive cells in in vitro 
staining of 12-week-old rat k idney 
Table 3. Results of kidney transplantations in the rats 
Donor Recipient No. Pretreatment Graft X ± SD 
strahl strain of ani- of the graft survival 
mals (days) 
LEW LEW 2 Perfusion mAb29A1 > 150, > 150 > 150 
DA LEW 10 Perfusion PBS 7,8, 7,8,8, 7, 7.7±0.5 
8,8,8,8 
DA LEW 5 Perfusion mAb 29 Al 10, 9, 11, 9, 9 9.6±0.8 
p <0.02 
LEW DA 3 Perfusion PBS 10, 8, 8 8.6 ± 1.1 
LEW DA 5 Perfusion mAb 29 A l 9,8,9, 10,9 9.0 ± 0.6 
DA LEW 5 Perfusion mAb 29 A 1 9,10, 8, 9 9.0 ±0.8 
anti mouse JgG p < 0.05 
rat complement 
DA LEW 2 Perfusion mAb 29 Al 8,9 8.5±0.5 
rabbit complement NS 
Fig.3. Section of rat kidney perfused with mAb 29Al and trans-
planted. Explantation done 4 h after grafting. Section incubated 
with anti-immunoglobulin conjugated with peroxidase. Interstitial 
dendritic cells are stained 
Fig. 4. Demonstration of donor-specific dass II -positive cells in reci-
pient's peripheral white pulp of spieen. Spleen of DA rat trans-
planted with LEW kidney. Section stained with anti-donor-specific 
dass II mAb (Ox3) 
proximal tubular cells were weakly stained (Fig. 3). Sec-
tians stained with Ox3 and Ox6 showed 42.9 ± 5.8 and 
83.8 ± 1.5/mm2 dass li-positive cells. Eight hours post-
operatively, the number of Iabelied interstitial DC was 
29.3 ± 4.2/mm2• Staining of additional sections with mAb 
Ox3 showed 33.8 ± 9.0/mm2 donor-specific dass !I-posi-
tive cells. Twenty-four hours after transplantation, only 
sporadic cells were weakly stained ( 6.5 ± 5 .3/mm2). At the 
same time, staining of kidney sections with anti-class li 
mAb Ox6 demonstrated the presence of 48.1 ± 8.0/mm2 
positive cells in interstitial tissue. Additional sections 
stained with anti-donor-specific dass II antigen Ox3 (in 
the LEW-to-DA system) showed 28.6 ± 2.7 cells/mm2 of 
donor origin. Thus, 24 h after transplantation, the nurober 
of donor DC was reduced and only 23% of them were la-
belled with mAb 29A1 given via perfusion. Forty-eight 
hours postoperatively, only a few cells was weakly stained, 
whereas 28.8 ± 7.1 cells/mm2 reacted with Ox3. A similar 
number of Ox3-positive cells were observed on day 3 post-
transplantation. These results showed that dissociation of 
the mAb begins earlier than emigration of DC and that 
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not all DC leave the graft during the first 3 days after 
transplantation. 
Migration of cells between the host and the graft 
On the basis of the observation that some regions of the 
kidney sections made 24--48 h after transplantation 
(LEW-DA) are depleted or even free of DC, recipient 
spieen and lymph nodes were analyzed for the presence of 
donor-specific class II cells. Donor-specific (LEW) 
class li-positive cells that reacted with mAb Ox3 were 
found in the peripheral white pulp ofthe recipient's (DA) 
spieen (Fig. 4 ). These cells were negative when stained 
with anti-mause immunoglobulin to detect mAb 29Al on 
their surfaces. There was a difference in the mean number 
of donor cells in the spieen between groups of rats pre-
treated with mAb 29A1 and those treated with PBS only 
(1.6 ± 0.6 versus 3.3 ± 1.7 cells per periarteriolar lym-
phoid sheath). In mesenteric lymph nodes of rats trans-
planted with argans perfused with PBS only, sporadic cells 
of donor dass li antigen were found, whereas in those per-
fused with mAb 29A1, none were found. 
Immunomorphological studies performed with MRC 
Ox3 in the DA-to-LEW system demonstrated that infil-
tration of the graft by recipient-specific dass II cells be-
gins 2 days after transplantation. 
Discussion 
Class II -positive interstitial DC are able to present alloan-
tigen as weil as to act as accessory cells [11, 15], and they 
constitute a major component of the renal cells that may 
induce graft rejection. Therefore, studies on blockade or 
elimination of these cells from the graft have been pro-
posed in the hope of proionging the survival of the graft. 
Several studies have been done with argans perfused with 
anti-MHC dass li mAbs. 
In 1983, Otsubo et al. [17] demonstrated that after per-
fusion of canine kidneys with anti-mause dass II antigens 
crossreacting with canine class II antigen, it is possible to 
prolang graft survival by a mean value of 15 days (7 days 
in the control group ). On the other side, Pollak et al. [18], 
who used the anti-rat dass II mAb Ox4, showed that this 
perfusion did not alter the immunogenicity of the graft, as 
there was no prolongation of renal graft survival. J ablon-
ski et al. [9] obtained similar results. 
Studies on pancreas transplantation have shown that a 
blockade of class II -positive cells in the graft did not 
change graft survival [4, 13, 14, 23]. In these studies, the ef-
fectiveness of the DC blockade was analyzed. They indi-
cated that nearly all cells were labelled. 
To better define the effectiveness of the procedure 
used for kidney graft pretreatment, we analyzed MHC 
dass II antigen expression in the normal rat kidney. The 
influence of age on dass II antigen expression was also 
studied. The results confirmed and extended earlier 
studies on dass II antigen expression in the kidney, which 
were, however, not quantitative [5, 6]. Ourstudies showed 
that all dass li-positive DC were Iabelied after a proce-
dure that included perfusion and 60 min of incubation. 
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Further sturlies have shown that this well-controlled 
procerlure for graft pretreatment prolongs the graft's sur-
vival. The extent to which it does is not satisfactory, how-
ever, from the biological point of view. In light of these re-
sults, the question arose as to whether rlissociation of an 
antiborly is a factor responsible for this only short prolon-
gation. lndeerl, the sturlies done on sections ofkidneys ex-
planterl at various time intervals after transplantation 
showerl that the mAb became rlissociaterl from the cell 
surface some hours after transplantation. 
For several years the view has been accepterl that sen-
sitization of the host against kirlney allograft occurs 
peripherally, within the graft. When we discovererl in 
sections of our grafts explanted 24 and 48 h after trans-
plantation that some regions of kidney tissue were free of 
DC, we considered this finding to be an effect of cytoiysis 
induced by the mAb, allowing reduced graft immunoge-
nicity. However, the brief survival of the perfused grafts 
led us to consider the alternative possibility that DC had 
migrated out of the graft and into the Iymphatic tissue of 
the recipient and, thus, participated in the induction of 
graft rejection. For this reason we performed immuno-
rnorphologicai studies on the recipient's spieen and lymph 
nodes. As described above, it was found that as early as 
1 day post-transplantation, rlonor-specific dass li-posi-
tive DC begin to leave the graft and migrate into lym-
phatic tissues, preferentially the spieen. Similar sturlies on 
animals grafted with kirlneys perfused with a mAb have 
shown that this procerlure results in rlecreased migration 
of rlonor cells into the recipient's lymphatic tissues. Early 
migration of DC from a cardiac graft into the recipient's 
spieen and localization in peripherai white pulp was ob-
served by Larsen et al. [10]. 
Taken together, this suggests that the rerluction of DC 
within the graft explanterl 24 and 48 h post-transplanta-
tion was the result of both rlepletion of their population 
and migration out of the graft. 
We wish to pointout that the number of dass li-posi-
tive DC within the graft shoulrl be considererl with cau-
tion, because some days after transplantation other cells, 
such as T lymphocytes or tubular epithelial cells, may be 
induced to express MHCdass li antigen. In ourperfusion 
experiments, however, induction of class II antigen on 
other cells may have been delayerl, a suggestion that is 
supporterl by our earlier observation that only after mAb 
perfusion was dass II antigen not expresserl on distal 
tubular cells 4 days after transplantation. 
Furthermore, considering that the mAb of IgGl class, 
which we used in our study, does not activate complement, 
with the result that it becomes sufficiently cytolytic, the 
fact that some rlonor DC persisterl within the graft is un-
derstanrlable. However, the combined perfusions with 
mAb, polydonal anti-mouse immunoglobulin, anrl com-
piement dirl not further prolong graft survival. Nor did 
destruction of DC within grafts by mAb targeted with 
A-chain ricin as immunotoxin [23] or by irradiation [9] in-
hibit graft rejection or prolang graft survival. Sturlies by 
Heart at al. (7] on retransplantation of rat kirlney to an-
other host showerl only marginal prolongation of alloge-
neic graft survival. However, retransplantation of long-
term surviving (DAxLEW) Fl grafts to fresh DA hosts, 
resulted in very prolonged survival. The authors suggest 
that this result rlepends on the loss of donor DC from the 
graft. 
On the seconrl day after transplantation, we observerl 
the beginning of infiltration of the graft by hast cells. It 
may, therefore, be concluderl that there is a bidirectional 
cell migration system between graft anrl host. 
Our transplantation experirnents showed that the sur-
vival of perfuserl grafts is only prolonged for about 3 days. 
This finrling is in accordance with the observation that 
rlonor DC do not remain labelled with mAb for Ionger 
than 24 h. After that time, DC retrieved their alloantigen 
presentation ability anrl induced rejection. 
Both migrating elements may participate in the inrluc-
tion of rejection by: (a) presentation of alloantigen by 
donor cells in the graft and Iater on in the recipient's 
spieen anrl (b) penetration of host cells into the graft and 
processing anrl presentation of alloantigen to T helper 
cells. The latter manner of alloantigen presentation has 
been suggested by Leehier and Batchelor [11 ], studied by 
Ishikura et al. [8], and confirmed by Sherwoorl et al. [20]. 
Participation of host cells in alloantigen presentation is 
goorl reason for combining mAb perfusion procedures 
with immunosuppression of the recipient. Thus, it may 
become possible ( a) to apply appropriately reduced doses 
of immunosuppressive drugs and (b) to induce tolerance, 
allowing such treatment to be stopperl several weeks or 
months after transplantation. Very promising studies 
along this line are in progress in our laboratory. 
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